BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9423132)

  • 1. [Effects of subcutaneous administration of erythropoietin on autologous blood predonation in open heart surgery: Japanese multicenter double-blinded dose-study].
    Omoto R; Kyo S; Furuse A; Hosoda Y; Eguchi S; Matsuda H; Kito Y; Hirashima K; Ogawa N
    Rinsho Kyobu Geka; 1994 Dec; 14(6):510-21. PubMed ID: 9423132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human recombinant erythropoietin on reduction of homologous blood transfusion in open-heart surgery. A Japanese Multicenter study.
    Kyo S; Omoto R; Hirashima K; Eguchi S; Fujita T
    Circulation; 1992 Nov; 86(5 Suppl):II413-8. PubMed ID: 1424032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A double-blind dose ranging study of weekly subcutaneous administration of rHuEPO (KRN5702) on post-phlebotomy anemia of patients scheduled for predeposit autologous blood transfusion (multicenter late PhII study)].
    Tsutsui H; Sugioka Y; Takaku F; Yamamura H; Asano S; Minami S; Wakimoto N; Takahashi K; Ikeda Y; Tachibana S
    Nihon Seikeigeka Gakkai Zasshi; 1993 Oct; 67(10):919-34. PubMed ID: 8263364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of recombinant human erythropoietin on autologous blood pre-donation in open heart surgery].
    Ono Y; Narita J; Takahashi S; Sawada M; Iwabuchi S; Tani A; Iwabuchi S; Shuto K; Fukui K; Kako N
    Kyobu Geka; 1991 Aug; 44(9):728-31. PubMed ID: 1956131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of preoperative treatment with recombinant human erythropoietin in patients undergoing hemodilutional autologous transfusion].
    Nakae Y; Sonoda H; Miyabe M; Kawamata M; Sakakibara N; Kawana S; Namiki A
    Masui; 1995 Oct; 44(10):1362-8. PubMed ID: 8538004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant human erythropoietin on autologous blood donation before open heart surgery.
    Schmoeckel M; Nollert G; Mempel M; Mempel W; Reichart B
    Thorac Cardiovasc Surg; 1993 Dec; 41(6):364-8. PubMed ID: 8128466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reduction of homologous blood in elective cardiac surgery with miscellaneous autologous blood transfusion--especially with short-term predonation method].
    Ohuchi H; Fukuda I
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Jul; 44(7):891-8. PubMed ID: 8741546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin response and route of administration.
    Taylor JE; Belch JJ; Fleming LW; Mactier RA; Henderson IS; Stewart WK
    Clin Nephrol; 1994 May; 41(5):297-302. PubMed ID: 8050210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
    Pizzarelli F; David S; Sala P; Icardi A; Casani A
    Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpatient variation in response to subcutaneous versus intravenous low dose erythropoietin.
    Barclay PG; Fischer ER; Harris DC
    Clin Nephrol; 1993 Nov; 40(5):277-80. PubMed ID: 8281716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous blood donation with recombinant human erythropoietin in cardiac surgery: the Japanese experience.
    Baron JF
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):64-7; discussion 68. PubMed ID: 8723586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preoperative autologous blood collection under erythropoietin stimulation. Preliminary results in patient selection, erythropoietin dosage and administration].
    Hochreiter J; Nietsche D; Oswald J; Jakubek H; Michlmayr G; Hohenwallner W
    Z Orthop Ihre Grenzgeb; 1992; 130(6):519-23. PubMed ID: 1492458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of recombinant human erythropoietin in cardiac surgery with autologous blood transfusion].
    Takanashi S; Kohama M; Aoki K; Furuta S; Numata K
    Nihon Kyobu Geka Gakkai Zasshi; 1991 Dec; 39(12):2140-4. PubMed ID: 1774500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery].
    Bisbe E; Sáez M; Nomen N; Castillo J; Santiveri X; Mestre C; Cano X
    Rev Esp Anestesiol Reanim; 2003 Oct; 50(8):395-400. PubMed ID: 14601367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predonation and transfusion in open heart surgery].
    Minami H; Wakita N; Kawahira T; Ozaki Y; Sakata M; Shida T
    Kyobu Geka; 1999 Aug; 52(9):747-50. PubMed ID: 10453165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Open heart surgery without homologous blood transfusion in elderly patients].
    Kanno S; Akimoto H; Nagamine S; Arai S; Sato S; Tabayashi K
    Kyobu Geka; 1997 Jul; 50(8 Suppl):702-6. PubMed ID: 9251498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
    Besarab A; Salifu MO; Lunde NM; Bansal V; Fishbane S; Dougherty FC; Beyer U;
    Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined erythropoietin and aprotinin use for blood conservation in elderly coronary bypass patients].
    Oshima N; Kiyama H; Imazeki T
    Kyobu Geka; 1997 Jul; 50(8 Suppl):707-10. PubMed ID: 9251499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.